Risk for subsequent coronary artery disease after preeclampsia.

[1]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[2]  N. Sattar,et al.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? , 2002, BMJ : British Medical Journal.

[3]  James M. Roberts,et al.  Contemporary concepts of the pathogenesis and management of preeclampsia. , 2002, JAMA.

[4]  J. Kooner,et al.  Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.

[5]  Jm Roberts,et al.  Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.

[6]  H. Laivuori,et al.  Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. , 1999, Obstetrics and gynecology.

[7]  I. Sargent,et al.  Preeclampsia: an excessive maternal inflammatory response to pregnancy. , 1999, American journal of obstetrics and gynecology.

[8]  S. Ferry,et al.  Cardiovascular sequelae of toxaemia of pregnancy. , 1997, Heart.

[9]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[10]  Lippincott Williams Wilkins,et al.  National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes , 1994, Hypertension.

[11]  A. Saftlas,et al.  Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. , 1990, American journal of obstetrics and gynecology.

[12]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[13]  R. Ness,et al.  Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy. , 2001, Hypertension in pregnancy.